Evidence map›Paper›PMID 37548361›Full record

ArticleeLife2023

Gautam Susarla, Priyanka Kataria, Amrita Kundu, Patrick D'Silva

Abstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. DJ-1 Serves as a Central Regulator of Diabetes Complications.Current issues in molecular biology · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gautam SusarlaDepartment of Biochemistry, Indian Institute of Science, Bangalore, India.ORCID 0000-0002-3798-749X
Priyanka Kataria *Department of Biochemistry, Indian Institute of Science, Bangalore, India.ORCID 0000-0003-1860-4286
Amrita Kundu *Department of Biochemistry, Indian Institute of Science, Bangalore, India.ORCID 0000-0002-1499-7564
Patrick D'SilvaDepartment of Biochemistry, Indian Institute of Science, Bangalore, India.ORCID 0000-0002-1619-5311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive carbonyl species (RCS) such as methylglyoxal and glyoxal are potent glycolytic intermediates that extensively damage cellular biomolecules leading to genetic aberration and protein misfolding. Hence, RCS levels are crucial indicators in the progression of various pathological diseases. Besides the glyoxalase system, emerging studies report highly conserved DJ-1 superfamily proteins as critical regulators of RCS. DJ-1 superfamily proteins, including the human DJ-1, a genetic determinant of Parkinson's disease, possess diverse physiological functions paramount for combating multiple stressors. Although

Indexed as

Nucleic AcidsSaccharomyces cerevisiae ProteinsGlyoxalHeat-Shock ProteinsHumansMaillard ReactionPyruvaldehydeSaccharomyces cerevisiaeGlyoxalHeat-Shock ProteinsNucleic AcidsPyruvaldehydeSaccharomyces cerevisiae Proteinsbiochemistrychemical biologydeglycation repairDicarbonyl stressDJ-1 family proteinsDNA glycationmitochondrial dysfunctionmitochondrial glycationS. cerevisiaeyeast Hsp31

Identifiers

PMID37548361
PMCPMC10431920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.